Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
PGEN | PRECIGEN, INC. | President and CEO, Director | $3.11M | May 31, 2024 | ||
KNTE | Kinnate Biopharma Inc. | Director | Apr 3, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|